**Core Concept**
Preventing contrast nephropathy involves administering drugs that either reduce the amount of contrast material used, improve renal blood flow, or mitigate the toxic effects of the contrast agent on the kidneys. The goal is to minimize the risk of contrast-induced acute kidney injury (CI-AKI).

**Why the Correct Answer is Right**
The most commonly used drugs to prevent contrast nephropathy include N-acetylcysteine (NAC), fenoldopam, and sodium bicarbonate. NAC acts as a free radical scavenger, reducing oxidative stress on the kidneys. Fenoldopam is a dopamine receptor agonist that increases renal blood flow and glomerular filtration rate (GFR). Sodium bicarbonate helps to maintain an alkaline urine pH, which reduces the precipitation of contrast material and its nephrotoxic effects.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it is not a commonly used medication for preventing contrast nephropathy. However, other drugs like dopamine and mannitol may be considered in specific clinical situations.
* **Option B:** This option is incorrect because while it may have some renal protective effects, it is not a primary drug used to prevent contrast nephropathy.
* **Option C:** This option is incorrect because it is not typically used for preventing contrast nephropathy. However, other medications like ascorbic acid and calcium channel blockers may have some renal protective effects.

**Clinical Pearl / High-Yield Fact**
When administering drugs to prevent contrast nephropathy, it is essential to consider the patient's underlying renal function, volume status, and potential interactions with other medications. Always follow institutional guidelines and consult with a nephrologist if necessary.

**Correct Answer:** A.